Medicine and Dentistry
Patient
72%
Erectile Dysfunction
38%
Man
35%
Age
30%
Neobladder
25%
Female
21%
Cystectomy
20%
Lower Urinary Tract Symptom
20%
Injection
19%
Inpatient
17%
Prostaglandin E1
15%
Evaluation Study
15%
Gender
13%
Male
13%
Stimulation
12%
Combination Therapy
12%
Woman
11%
Sex Difference
11%
Hemodynamic
11%
Relaxation
11%
International Prostate Symptom Score
10%
Stress
10%
Atropine
10%
Patient Satisfaction
10%
Percutaneous Nephrolithotomy
10%
Infant
10%
Mechanism of Action
10%
Visual Stimulation
10%
Bowel Obstruction
10%
Metabolic Syndrome
10%
Retrospective Cohort Study
10%
Experience
10%
Health
10%
Botulinum Toxin A
10%
Vulvodynia
10%
Perception
10%
Brain
10%
Aging
10%
Intracavernous Injection
9%
Surgery
9%
Association
9%
Paralytic Ileus
8%
Phosphodiesterase V Inhibitor
8%
Pain
8%
Diagnosis
7%
Artery Blood Flow
7%
Complication
7%
Stone
7%
Bladder Cancer
7%
Symptom
6%
Pharmacology, Toxicology and Pharmaceutical Science
Erectile Dysfunction
100%
Placebo
53%
Blindness
37%
Udenafil
30%
Mirodenafil
25%
Antihypertensive Agent
20%
Controlled Clinical Trial
20%
Prostate Hypertrophy
15%
Phosphodiesterase V Inhibitor
14%
Symptom
13%
Adverse Event
10%
Prostaglandin E1
10%
Lower Urinary Tract Symptom
10%
Cohort Study
10%
Diabetes Mellitus
10%
Vardenafil
10%
Phase IV
10%
Monotherapy
7%
Premature Ejaculation
6%
Adverse Drug Reaction
5%
Tolerability
5%
Atropine
5%
Alpha Adrenergic Receptor Blocking Agent
5%
Clinical Study
5%
Obesity
5%
Ginseng
5%
Leporidae
5%